Literature DB >> 11242186

Developing AIDS vaccine trials educational programs in Uganda.

J W McGrath1, D Mafigiri, M Kamya, K George, R Senvewo, G Svilar, M Kabugo, E Mugisha.   

Abstract

In preparation for HIV vaccine trials, data on a cohort's knowledge about vaccines and vaccine studies are required so as to tailor educational materials to adequately meet local needs. Interviews (n = 1,182) conducted as part of a 3-year prospective study of Ugandan military men aged 18 to 30 years determined what information, in addition to standard trials information, would be required to ensure comprehension of trial procedures. The interviews highlighted four points: (1) the cohort has a lot of knowledge about vaccines but conflates whether vaccines cure or prevent disease; (2) there is a general lack of knowledge about clinical trials procedures; (3) the desire to be protected from HIV/AIDS is a common reason for being willing to participate in a hypothetical vaccine trial; and (4) concern about side effects is a common reason for being unwilling to participate in a trial. These four points guided the focus of the vaccine trials education, which used locally appropriate analogies to introduce complex unfamiliar concepts such as placebos and blinding. This case study highlights the value of incorporating baseline interviews to assess the educational needs of study populations.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11242186     DOI: 10.1097/00042560-200102010-00012

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  5 in total

Review 1.  First trial of the HIV-1 vaccine in Africa: Ugandan experience.

Authors:  Roy D Mugerwa; Pontiano Kaleebu; Peter Mugyenyi; Edward Katongole-Mbidde; David L Hom; Rose Byaruhanga; Robert A Salata; Jerrold J Ellner
Journal:  BMJ       Date:  2002-01-26

Review 2.  Socio-behaviour challenges to phase III HIV vaccine trials in Sub-Saharan Africa.

Authors:  Joalida Smit; Keren Middelkoop; Landon Myer; Graham Lindegger; Leslie Swartz; Soraya Seedat; Tim Tucker; Robin Wood; Linda-Gail Bekker; Dan J Stein
Journal:  Afr Health Sci       Date:  2005-09       Impact factor: 0.927

3.  Behavioral and social science research to support development of educational materials for clinical trials of broadly neutralizing antibodies for HIV treatment and prevention.

Authors:  Pablo K Valente; Yumeng Wu; Yehuda Z Cohen; Marina Caskey; Kathrine Meyers
Journal:  Clin Trials       Date:  2020-08-24       Impact factor: 2.486

4.  Repeated assessments of informed consent comprehension among HIV-infected participants of a three-year clinical trial in Botswana.

Authors:  Lelia H Chaisson; Nancy E Kass; Bafanana Chengeta; Unami Mathebula; Taraz Samandari
Journal:  PLoS One       Date:  2011-10-27       Impact factor: 3.240

5.  "You would not be in a hurry to go back home": patients' willingness to participate in HIV/AIDS clinical trials at a clinical and research facility in Kampala, Uganda.

Authors:  Deborah Ekusai Sebatta; Godfrey Siu; Henry W Nabeta; Godwin Anguzu; Stephen Walimbwa; Mohammed Lamorde; Badru Bukenya; Andrew Kambugu
Journal:  BMC Med Ethics       Date:  2020-08-24       Impact factor: 2.652

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.